交联羧甲基纤维素和丝蛋白用于干眼病管理和角膜伤口愈合:体内和体外结果。

IF 3.3 4区 医学 Q1 Medicine
F Scarinci, G De Simone, G Coco, C Caggiano, G Pocobelli, F Boselli, A Di Masi
{"title":"交联羧甲基纤维素和丝蛋白用于干眼病管理和角膜伤口愈合:体内和体外结果。","authors":"F Scarinci, G De Simone, G Coco, C Caggiano, G Pocobelli, F Boselli, A Di Masi","doi":"10.26355/eurrev_202602_37688","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This retrospective cohort study aims to uncover the potential clinical effectiveness of a novel ophthalmic solution containing cross-linked carboxymethyl cellulose (CX-CMC) and silk proteins (SP) in dry eye disease, evaluating its efficacy in improving Tear Breakup Time (TBUT) and Ocular Surface Disease Index (OSDI) over a 3-months treatment and in absorbing ultraviolet (UV) and blue light and promoting wound healing.</p><p><strong>Materials and methods: </strong>Two different populations were retrieved from the database; the first group consisted of 20 dry-eye patients who underwent a 3-month treatment with an ophthalmic solution containing CX-CMC and SP. The second group was composed of 10 dry-eye patients who did not want to use any eye lubricant or other treatment. The outcome measures, TBUT and OSDI, were analyzed before (T0) and after (T3) treatment. In addition, the ophthalmic solution was investigated for its capacity to absorb UV and blue light and to promote wound healing. Specifically, UV and blue absorbance were tested by means of a UV-VIS spectrophotometer, while the wound healing test was conducted using two distinct cell lines to assess the efficacy of the solution in facilitating cicatrization.</p><p><strong>Results: </strong>The ophthalmic solution effectively restored tear film stability, as evidenced by the improved TBUT values and reduced dry eye disease symptoms evaluated through the OSDI score. Furthermore, it demonstrated absorption capabilities within the UV and blue wavelength range. In terms of wound recovery, the ophthalmic solution supported cell motility compared to untreated cells.</p><p><strong>Conclusions: </strong>The ophthalmic solution containing CX-CMC and SP was effective in improving dry-eye signs and symptoms in patients and in absorbing UV and blue light. Furthermore, the ophthalmic solution promoted wound healing in vitro. Collectively, the results suggest that CX-CMC and SP eye drops could serve as a promising tool for treating dry eye disease of various origins.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"30 2","pages":"62-70"},"PeriodicalIF":3.3000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cross-linked carboxymethyl cellulose and silk proteins for dry eye disease management and corneal wound healing: in vivo and in vitro results.\",\"authors\":\"F Scarinci, G De Simone, G Coco, C Caggiano, G Pocobelli, F Boselli, A Di Masi\",\"doi\":\"10.26355/eurrev_202602_37688\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This retrospective cohort study aims to uncover the potential clinical effectiveness of a novel ophthalmic solution containing cross-linked carboxymethyl cellulose (CX-CMC) and silk proteins (SP) in dry eye disease, evaluating its efficacy in improving Tear Breakup Time (TBUT) and Ocular Surface Disease Index (OSDI) over a 3-months treatment and in absorbing ultraviolet (UV) and blue light and promoting wound healing.</p><p><strong>Materials and methods: </strong>Two different populations were retrieved from the database; the first group consisted of 20 dry-eye patients who underwent a 3-month treatment with an ophthalmic solution containing CX-CMC and SP. The second group was composed of 10 dry-eye patients who did not want to use any eye lubricant or other treatment. The outcome measures, TBUT and OSDI, were analyzed before (T0) and after (T3) treatment. In addition, the ophthalmic solution was investigated for its capacity to absorb UV and blue light and to promote wound healing. Specifically, UV and blue absorbance were tested by means of a UV-VIS spectrophotometer, while the wound healing test was conducted using two distinct cell lines to assess the efficacy of the solution in facilitating cicatrization.</p><p><strong>Results: </strong>The ophthalmic solution effectively restored tear film stability, as evidenced by the improved TBUT values and reduced dry eye disease symptoms evaluated through the OSDI score. Furthermore, it demonstrated absorption capabilities within the UV and blue wavelength range. In terms of wound recovery, the ophthalmic solution supported cell motility compared to untreated cells.</p><p><strong>Conclusions: </strong>The ophthalmic solution containing CX-CMC and SP was effective in improving dry-eye signs and symptoms in patients and in absorbing UV and blue light. Furthermore, the ophthalmic solution promoted wound healing in vitro. Collectively, the results suggest that CX-CMC and SP eye drops could serve as a promising tool for treating dry eye disease of various origins.</p>\",\"PeriodicalId\":12152,\"journal\":{\"name\":\"European review for medical and pharmacological sciences\",\"volume\":\"30 2\",\"pages\":\"62-70\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2026-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European review for medical and pharmacological sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26355/eurrev_202602_37688\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202602_37688","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:本回顾性队列研究旨在揭示含有交联羧甲基纤维素(CX-CMC)和丝蛋白(SP)的新型眼液治疗干眼病的潜在临床疗效,评估其在3个月治疗期间改善泪液破裂时间(TBUT)和眼表疾病指数(OSDI)以及吸收紫外线(UV)和蓝光和促进伤口愈合方面的疗效。材料和方法:从数据库中检索两个不同的种群;第一组由20名干眼症患者组成,他们接受了含有CX-CMC和SP的眼液治疗3个月。第二组由10名干眼症患者组成,他们不想使用任何眼睛润滑剂或其他治疗。分析治疗前(T0)和治疗后(T3)的TBUT和OSDI指标。此外,还研究了该眼液吸收紫外线和蓝光以及促进伤口愈合的能力。具体来说,通过紫外-可见分光光度计测试紫外线和蓝色吸光度,同时使用两种不同的细胞系进行伤口愈合测试,以评估溶液促进愈合的功效。结果:眼液有效地恢复了泪膜的稳定性,通过OSDI评分评估的TBUT值的改善和干眼病症状的减轻证明了这一点。此外,它还显示了在紫外线和蓝色波长范围内的吸收能力。在伤口恢复方面,与未处理的细胞相比,眼液支持细胞运动。结论:含CX-CMC和SP的眼液能有效改善患者的干眼体征和症状,并能吸收紫外线和蓝光。此外,眼液促进伤口体外愈合。综上所述,CX-CMC和SP滴眼液可以作为治疗各种来源的干眼病的有希望的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cross-linked carboxymethyl cellulose and silk proteins for dry eye disease management and corneal wound healing: in vivo and in vitro results.

Objective: This retrospective cohort study aims to uncover the potential clinical effectiveness of a novel ophthalmic solution containing cross-linked carboxymethyl cellulose (CX-CMC) and silk proteins (SP) in dry eye disease, evaluating its efficacy in improving Tear Breakup Time (TBUT) and Ocular Surface Disease Index (OSDI) over a 3-months treatment and in absorbing ultraviolet (UV) and blue light and promoting wound healing.

Materials and methods: Two different populations were retrieved from the database; the first group consisted of 20 dry-eye patients who underwent a 3-month treatment with an ophthalmic solution containing CX-CMC and SP. The second group was composed of 10 dry-eye patients who did not want to use any eye lubricant or other treatment. The outcome measures, TBUT and OSDI, were analyzed before (T0) and after (T3) treatment. In addition, the ophthalmic solution was investigated for its capacity to absorb UV and blue light and to promote wound healing. Specifically, UV and blue absorbance were tested by means of a UV-VIS spectrophotometer, while the wound healing test was conducted using two distinct cell lines to assess the efficacy of the solution in facilitating cicatrization.

Results: The ophthalmic solution effectively restored tear film stability, as evidenced by the improved TBUT values and reduced dry eye disease symptoms evaluated through the OSDI score. Furthermore, it demonstrated absorption capabilities within the UV and blue wavelength range. In terms of wound recovery, the ophthalmic solution supported cell motility compared to untreated cells.

Conclusions: The ophthalmic solution containing CX-CMC and SP was effective in improving dry-eye signs and symptoms in patients and in absorbing UV and blue light. Furthermore, the ophthalmic solution promoted wound healing in vitro. Collectively, the results suggest that CX-CMC and SP eye drops could serve as a promising tool for treating dry eye disease of various origins.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.30
自引率
6.10%
发文量
906
审稿时长
2-4 weeks
期刊介绍: European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书